An Economic Evaluation of Continuous Glucose Monitoring for People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia within North West London Clinical Commissioning Groups in England
Open Access
- 1 January 2017
- journal article
- Published by Touch Medical Media, Ltd. in touchREVIEWS in Endocrinology
- Vol. 13 (2), 81-85
- https://doi.org/10.17925/ee.2017.13.02.81
Abstract
Objective: To assess the economic impact of providing real time continuous glucose monitoring (CGM) for people with type 1 diabetes (T1D) and impaired awareness of hypoglycaemia (IAH) within North West (NW) London clinical commissioning groups (CCGs). Methods: The eligible population for CGM and inputs for the economic budget impact model developed were derived from published data. The model includes cost of CGM; cost savings associated with lower hypoglycaemia related hospital admissions, accidents and emergency visits; self-monitoring of blood glucose (SMBG) strip usage; and glycated haemoglobin (HbA1c) reduction-related avoided complications and insulin pump use. Results: The cost of CGM for T1D-IAH (n=3,036) in the first year is £10,770,671 and in the fourth year is £11,329,095. The combined cost off-sets related to reduced hypoglycaemia admissions, SMBG strip usage and complications are £8,116,912 and £8,741,026 in years one and four, respectively. The net budget impact within the NW London CCGs is £2,653,760; £2,588,068 in years one and four respectively. Conclusions: Introduction of CGM for T1D-IAH patients will have a minimal budget impact on NW London CCGs, driven by cost of CGM and offsets from lower hypoglycaemia-related costs, reduced SMBG strip usage, avoided HbA1c-related complications and lower insulin pump use.Keywords
This publication has 35 references indexed in Scilit:
- Contemporary rates of severe hypoglycaemia in youth with Type 1 diabetes: variability by insulin regimenDiabetic Medicine, 2012
- Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetesCost Effectiveness and Resource Allocation, 2011
- The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 DiabetesDiabetes Care, 2010
- Effectiveness of Continuous Glucose Monitoring in a Clinical Care EnvironmentDiabetes Care, 2009
- Impaired Awareness of Hypoglycemia in a Population-Based Sample of Children and Adolescents With Type 1 DiabetesDiabetes Care, 2009
- Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetesDiabetic Medicine, 2008
- Defining and Reporting Hypoglycemia in DiabetesDiabetes Care, 2005
- Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selectionDiabetes/Metabolism Research and Reviews, 2004
- Frequency of Severe Hypoglycemia in Patients With Type I Diabetes With Impaired Awareness of HypoglycemiaDiabetes Care, 1994
- Frequency and Morbidity of Severe Hypoglycaemia in Insulin‐treated Diabetic PatientsDiabetic Medicine, 1993